Efficacy News and Research

RSS
GATTEX Phase 3 study results in adult short bowel syndrome presented at DDW 2011

GATTEX Phase 3 study results in adult short bowel syndrome presented at DDW 2011

Journal of Rheumatology publishes positive results from Cimzia Phase III trial in RA

Journal of Rheumatology publishes positive results from Cimzia Phase III trial in RA

Adherence to disease-modifying drugs is low in patients with multiple sclerosis

Adherence to disease-modifying drugs is low in patients with multiple sclerosis

3M introduces Clean-Trace Hygiene Management System for healthcare facilities

3M introduces Clean-Trace Hygiene Management System for healthcare facilities

Dalbavancin surveillance antibiotic results for Gram-positive pathogens presented at ECCMID meeting

Dalbavancin surveillance antibiotic results for Gram-positive pathogens presented at ECCMID meeting

Insmed first quarter revenues decrease to $1.6 million

Insmed first quarter revenues decrease to $1.6 million

Tetraphase presents TP-434, TP-2758 antibiotics study data against pathogens at ECCMID

Tetraphase presents TP-434, TP-2758 antibiotics study data against pathogens at ECCMID

Multiband mucosectomy safe and effective for treating Barrett's esophagus

Multiband mucosectomy safe and effective for treating Barrett's esophagus

biocrea and Pfizer jointly presented details on novel PDE10 inhibitors

biocrea and Pfizer jointly presented details on novel PDE10 inhibitors

MGH, Duke University and Angion Biomedica partner to develop novel therapeutics for ischemic stroke

MGH, Duke University and Angion Biomedica partner to develop novel therapeutics for ischemic stroke

CHOP forms first startup firm to develop treatments for peripheral artery disease

CHOP forms first startup firm to develop treatments for peripheral artery disease

Kowa presents three K-115 study results against glaucoma at ARVO 2011

Kowa presents three K-115 study results against glaucoma at ARVO 2011

Abbott, Sucampo present lubiprostone phase 3 trial data in Japanese CIC at DDW 2011

Abbott, Sucampo present lubiprostone phase 3 trial data in Japanese CIC at DDW 2011

GTx reports net loss of $2.6 million for first quarter 2011

GTx reports net loss of $2.6 million for first quarter 2011

CSEW fails to protect public health by refusing to take part in variant Creutzfeldt-Jakob disease study

CSEW fails to protect public health by refusing to take part in variant Creutzfeldt-Jakob disease study

Inovio reports VGX-3100 Phase I study data in cervical dysplasia and cancer

Inovio reports VGX-3100 Phase I study data in cervical dysplasia and cancer

Diamyd Medical announces European Phase III study results in type 1 diabetes

Diamyd Medical announces European Phase III study results in type 1 diabetes

Mithridion's MCD-386CR receives Orphan Drug designation from FDA for PSP treatment

Mithridion's MCD-386CR receives Orphan Drug designation from FDA for PSP treatment

Current Opinion in Immunology journal publishes Inovio's article on DNA vaccines

Current Opinion in Immunology journal publishes Inovio's article on DNA vaccines

Cempra to present solithromycin Phase 1 study data at ECCMID/ICC meeting

Cempra to present solithromycin Phase 1 study data at ECCMID/ICC meeting

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.